학술논문

A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer.
Document Type
Article
Source
Oncologist; Dec2020, Vol. 25 Issue 12, pe1893-e1899, 7p, 3 Charts, 3 Graphs
Subject
THERAPEUTIC use of antineoplastic agents
CELLULAR signal transduction
CLINICAL trials
CONFIDENCE intervals
HEPATOCELLULAR carcinoma
HETEROCYCLIC compounds
TUMOR classification
TREATMENT effectiveness
DATA analysis software
DESCRIPTIVE statistics
SORAFENIB
Language
ISSN
10837159
Abstract
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)